dapagliflozin 10 MG Oral Tablet

RxCUI: 1488569
RxNorm name: dapagliflozin 10 MG Oral Tablet
Display name: Dapagliflozin (Oral Pill)
Full name: dapagliflozin 10 MG Oral Tablet
Term type: SCD
Status: Active
Strength: 10 mg
Dose form: Tab
Route: Oral Pill
Updated: 2026-08-18 06:18:10

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 032014
Active start: 032014
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
dapagliflozin	10 MG / 1 EACH	dapagliflozin	dapagliflozin

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Tablet	317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
dapagliflozin	1488564

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	dapagliflozin 10 MG Oral Tablet	1	NAMES
RxNorm Name	dapagliflozin 10 MG Oral Tablet	1	NAMES
RxNorm Synonym	dapagliflozin 10 MG Oral Tablet	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	22 linked values 3aba33aa-f8c6-4b10-85c8-dfa14578d07c 08baca21-e39e-4e61-961f-d89432fe8007 20a83ea2-6ad8-4bbb-b516-73c0a9e37399 52a778e7-6044-2049-e063-6294a90aa0b7 107b4d25-4764-42b7-80e3-9aaff20865ed 0406a1c0-56b1-4ea1-95ae-00357ac1ba7e 828f1004-3647-9a13-8008-c4b3759ecfd0 840e2146-2383-489b-bcc4-fecfe986685a 6425d240-5dd9-4a2c-9348-f8a859702850 8296f538-4c23-4d6c-be53-8005b83c24b7 17586ec6-0104-4b08-ad87-12a837568d6c 979205ee-b0b8-4483-ae61-f283f750bb7f 87521963-0d2a-4a2a-89c6-d50e8582419e 91373924-66dc-4277-aaf2-8536e81a0e4d a2f86c0a-ce78-4d06-b5d8-ed457c8e3614 addc6ead-f9e3-4b40-aed1-bc008a5c9b0f b6b8a10c-64c3-4856-8961-d72d68784f5d bd9766c5-104f-4636-897d-b6c92eb94f18 d44f7eed-dd51-40d1-8408-8fb331e1f1f6 db668c5c-2d49-41c8-8ffd-c2b2652b621a f615d81e-d1e8-4561-a4d9-286c615d3bd2 f56593f7-588e-489d-9fad-b459e90dab18	22	CODES
RxCUI	1488569	1	CODES
MMSL_CODE	2 linked values BD28023 CD28023	2	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0480-3528-05	0480-3528	DAPAGLIFLOZIN DAPAGLIFLOZIN	Teva Pharmaceuticals, Inc.	ANDA211541
0480-3528-56	0480-3528	DAPAGLIFLOZIN DAPAGLIFLOZIN	Teva Pharmaceuticals, Inc.	ANDA211541
0480-3528-98	0480-3528	DAPAGLIFLOZIN DAPAGLIFLOZIN	Teva Pharmaceuticals, Inc.	ANDA211541
0781-5990-01	0781-5990	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
0781-5990-05	0781-5990	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
0781-5990-10	0781-5990	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
0781-5990-31	0781-5990	Dapagliflozin Dapagliflozin	Sandoz Inc	ANDA211312
27241-152-01	27241-152	Dapagliflozin Dapagliflozin	Ajanta Pharma USA Inc.	ANDA211482
33342-586-07	33342-586	dapagliflozin dapagliflozin	Macleods Pharmaceuticals Limited	ANDA211506
33342-586-10	33342-586	dapagliflozin dapagliflozin	Macleods Pharmaceuticals Limited	ANDA211506
33342-586-56	33342-586	dapagliflozin dapagliflozin	Macleods Pharmaceuticals Limited	ANDA211506
46708-393-30	46708-393	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Limited	ANDA211560
46708-393-91	46708-393	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Limited	ANDA211560
50090-7057-0	50090-7057	DAPAGLIFLOZIN DAPAGLIFLOZIN	A-S Medication Solutions	NDA202293
50090-7972-0	50090-7972	Dapagliflozin Dapagliflozin	A-S Medication Solutions	ANDA211468
59651-160-30	59651-160	Dapagliflozin Dapagliflozin	Aurobindo Pharma Limited	ANDA211468
59651-160-90	59651-160	Dapagliflozin Dapagliflozin	Aurobindo Pharma Limited	ANDA211468
60505-4912-3	60505-4912	Dapagliflozin DAPAGLIFLOZIN	Apotex Corp.	ANDA211523
62332-393-30	62332-393	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Inc.	ANDA211560
62332-393-91	62332-393	DAPAGLIFLOZIN DAPAGLIFLOZIN	Alembic Pharmaceuticals Inc.	ANDA211560
63629-3253-1	63629-3253	DAPAGLIFLOZIN DAPAGLIFLOZIN	Bryant Ranch Prepack	NDA202293
66993-457-30	66993-457	DAPAGLIFLOZIN DAPAGLIFLOZIN	Prasco Laboratories	NDA202293
67877-609-05	67877-609	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
67877-609-30	67877-609	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
67877-609-33	67877-609	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
67877-609-90	67877-609	Dapagliflozin Dapagliflozin	Ascend Laboratories, LLC	ANDA211545
69097-389-02	69097-389	DAPAGLIFLOZIN DAPAGLIFLOZIN	Cipla USA Inc.	ANDA211535
70377-024-11	70377-024	DAPAGLIFLOZIN DAPAGLIFLOZIN	Biocon Pharma Inc.	ANDA211470
70377-024-12	70377-024	DAPAGLIFLOZIN DAPAGLIFLOZIN	Biocon Pharma Inc.	ANDA211470
70710-1381-3	70710-1381	Dapagliflozin Dapagliflozin	Zydus Pharmaceuticals USA Inc.	ANDA211582
70710-1381-9	70710-1381	Dapagliflozin Dapagliflozin	Zydus Pharmaceuticals USA Inc.	ANDA211582
70748-106-06	70748-106	Dapagliflozin Dapagliflozin	Lupin Pharmaceuticals, Inc.	ANDA211531
70771-1715-3	70771-1715	Dapagliflozin Dapagliflozin	Zydus Lifesciences Limited	ANDA211582
70771-1715-9	70771-1715	Dapagliflozin Dapagliflozin	Zydus Lifesciences Limited	ANDA211582
70954-857-10	70954-857	Dapagliflozin Dapagliflozin	ANI Pharmaceuticals, Inc.	ANDA211156
71921-421-09	71921-421	DAPAGLIFLOZIN Dapagliflozin	Florida Pharmaceutical Products, LLC	ANDA211156
71921-421-33	71921-421	DAPAGLIFLOZIN Dapagliflozin	Florida Pharmaceutical Products, LLC	ANDA211156
71921-421-50	71921-421	DAPAGLIFLOZIN Dapagliflozin	Florida Pharmaceutical Products, LLC	ANDA211156
72205-433-01	72205-433	Dapagliflozin Dapagliflozin	Novadoz Pharmaceuticals LLC	ANDA211478
72205-433-02	72205-433	Dapagliflozin Dapagliflozin	Novadoz Pharmaceuticals LLC	ANDA211478
72205-433-03	72205-433	Dapagliflozin Dapagliflozin	Novadoz Pharmaceuticals LLC	ANDA211478
73190-073-30	73190-073	Dapagliflozin Dapagliflozin	AvKARE	ANDA211478
73190-073-90	73190-073	Dapagliflozin Dapagliflozin	AvKARE	ANDA211478

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA211541	0480-3528	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Teva Pharmaceuticals, Inc.
ANDA211312	0781-5990	Dapagliflozin Dapagliflozin	ANDA	Sandoz Inc
ANDA211482	27241-152	Dapagliflozin Dapagliflozin	ANDA	Ajanta Pharma USA Inc.
ANDA211506	33342-586	dapagliflozin dapagliflozin	ANDA	Macleods Pharmaceuticals Limited
ANDA211560	46708-393	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Alembic Pharmaceuticals Limited
NDA202293	50090-7057	DAPAGLIFLOZIN DAPAGLIFLOZIN	NDA AUTHORIZED GENERIC	A-S Medication Solutions
ANDA211468	50090-7972	Dapagliflozin Dapagliflozin	ANDA	A-S Medication Solutions
ANDA211523	60505-4912	Dapagliflozin DAPAGLIFLOZIN	ANDA	Apotex Corp.
ANDA211545	67877-609	Dapagliflozin Dapagliflozin	ANDA	Ascend Laboratories, LLC
ANDA211535	69097-389	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Cipla USA Inc.
ANDA211470	70377-024	DAPAGLIFLOZIN DAPAGLIFLOZIN	ANDA	Biocon Pharma Inc.
ANDA211582	70710-1381	Dapagliflozin Dapagliflozin	ANDA	Zydus Pharmaceuticals USA Inc.
ANDA211531	70748-106	Dapagliflozin Dapagliflozin	ANDA	Lupin Pharmaceuticals, Inc.
ANDA211156	70954-857	Dapagliflozin Dapagliflozin	ANDA	ANI Pharmaceuticals, Inc.
ANDA211478	72205-433	Dapagliflozin Dapagliflozin	ANDA	Novadoz Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 46 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00480352805	rxnav_ndcs	yes
00480352856	rxnav_ndcs	yes
00480352898	rxnav_ndcs	yes
00781599001	rxnav_ndcs	yes
00781599005	rxnav_ndcs	yes
00781599010	rxnav_ndcs	yes
00781599031	rxnav_ndcs	yes
27241015201	rxnav_ndcs	yes
33342058607	rxnav_ndcs	yes
33342058610	rxnav_ndcs	yes
33342058656	rxnav_ndcs	yes
33342058666	rxnav_ndcs	yes
46708039330	rxnav_ndcs	yes
46708039390	rxnav_ndcs	yes
46708039391	rxnav_ndcs	yes
50090705700	rxnav_ndcs	yes
50090797200	rxnav_ndcs	yes
59651016030	rxnav_ndcs	yes
59651016090	rxnav_ndcs	yes
60505491203	rxnav_ndcs	yes
62332039330	rxnav_ndcs	yes
62332039390	rxnav_ndcs	yes
62332039391	rxnav_ndcs	yes
63629325301	rxnav_ndcs	yes
66993045730	rxnav_ndcs	yes
67877060905	rxnav_ndcs	yes
67877060930	rxnav_ndcs	yes
67877060933	rxnav_ndcs	yes
67877060990	rxnav_ndcs	yes
69097038902	rxnav_ndcs	yes
70377002411	rxnav_ndcs	yes
70377002412	rxnav_ndcs	yes
70710138103	rxnav_ndcs	yes
70710138109	rxnav_ndcs	yes
70748010606	rxnav_ndcs	yes
70771171503	rxnav_ndcs	yes
70771171509	rxnav_ndcs	yes
70954085710	rxnav_ndcs	yes
71921042109	rxnav_ndcs	yes
71921042133	rxnav_ndcs	yes
71921042150	rxnav_ndcs	yes
72205043301	rxnav_ndcs	yes
72205043302	rxnav_ndcs	yes
72205043303	rxnav_ndcs	yes
73190007330	rxnav_ndcs	yes
73190007390	rxnav_ndcs	yes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 24 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dapagliflozin	DAPAGLIFLOZIN	Sandoz Inc	8296f538-4c23-4d6c-be53-8005b83c24b7	2026-07-30	Warnings, Adverse reactions	Exact identifier ndc (package): 0781-5990-31 ndc (package): 0781-5990-05 ndc (package): 0781-5990-01 ndc (package): 0781-5990-10 ndc (product): 0781-5990 ndc11 (package): 00781599031 ndc11 (package): 00781599005 ndc11 (package): 00781599001 ndc11 (package): 00781599010
Dapagliflozin	DAPAGLIFLOZIN	Aurobindo Pharma Limited	f56593f7-588e-489d-9fad-b459e90dab18	2026-07-17	Warnings, Adverse reactions	Exact identifier ndc (package): 59651-160-30 ndc (package): 59651-160-90 ndc (product): 59651-160 ndc11 (package): 59651016030 ndc11 (package): 59651016090 rxcui: 1488569
FARXIGA	DAPAGLIFLOZIN	A-S Medication Solutions	01f90c94-71cb-4a1f-81ff-8004b850529b	2026-07-10	Warnings, Adverse reactions	Exact identifier rxcui: 1488569
dapagliflozin	DAPAGLIFLOZIN	Macleods Pharmaceuticals Limited	91373924-66dc-4277-aaf2-8536e81a0e4d	2026-07-09	Warnings, Adverse reactions	Exact identifier ndc (package): 33342-586-10 ndc (package): 33342-586-07 ndc (package): 33342-586-56 ndc (product): 33342-586 ndc11 (package): 33342058656 ndc11 (package): 33342058610 ndc11 (package): 33342058607 ndc11 (package): 33342058666 rxcui: 1488569
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Florida Pharmaceutical Products, LLC	20a83ea2-6ad8-4bbb-b516-73c0a9e37399	2026-07-02	Warnings, Adverse reactions	Exact identifier ndc (package): 71921-421-50 ndc (package): 71921-421-33 ndc (package): 71921-421-09 ndc (product): 71921-421 ndc11 (package): 71921042109 ndc11 (package): 71921042150 ndc11 (package): 71921042133 rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	ANI Pharmaceuticals, Inc.	6425d240-5dd9-4a2c-9348-f8a859702850	2026-06-29	Warnings, Adverse reactions	Exact identifier ndc (package): 70954-857-10 ndc (product): 70954-857 ndc11 (package): 70954085710 rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	Ascend Laboratories, LLC	b6b8a10c-64c3-4856-8961-d72d68784f5d	2026-06-25	Warnings, Adverse reactions	Exact identifier ndc (package): 67877-609-90 ndc (package): 67877-609-30 ndc (package): 67877-609-33 ndc (package): 67877-609-05 ndc (product): 67877-609 ndc11 (package): 67877060930 ndc11 (package): 67877060990 ndc11 (package): 67877060905 ndc11 (package): 67877060933 rxcui: 1488569
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Alembic Pharmaceuticals Inc.	840e2146-2383-489b-bcc4-fecfe986685a	2026-06-23	Warnings, Adverse reactions	Exact identifier ndc (package): 62332-393-30 ndc (package): 62332-393-91 ndc (product): 62332-393 ndc11 (package): 62332039330 ndc11 (package): 62332039390 ndc11 (package): 62332039391 rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	Zydus Pharmaceuticals USA Inc.	17586ec6-0104-4b08-ad87-12a837568d6c	2026-06-22	Warnings, Adverse reactions	Exact identifier ndc (package): 70710-1381-3 ndc (package): 70710-1381-9 ndc (product): 70710-1381 ndc11 (package): 70710138103 ndc11 (package): 70710138109 rxcui: 1488569
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Cipla USA Inc.	a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	2026-06-22	Warnings, Adverse reactions	Exact identifier ndc (package): 69097-389-02 ndc (product): 69097-389 ndc11 (package): 69097038902
Dapagliflozin	DAPAGLIFLOZIN	Novadoz Pharmaceuticals LLC	107b4d25-4764-42b7-80e3-9aaff20865ed	2026-06-17	Warnings, Adverse reactions	Exact identifier ndc (package): 72205-433-02 ndc (package): 72205-433-03 ndc (package): 72205-433-01 ndc (product): 72205-433 ndc11 (package): 72205043302 ndc11 (package): 72205043303 ndc11 (package): 72205043301 rxcui: 1488569
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Prasco Laboratories	3aba33aa-f8c6-4b10-85c8-dfa14578d07c	2026-06-03	Warnings, Adverse reactions	Exact identifier ndc (package): 66993-457-30 ndc (product): 66993-457 ndc11 (package): 66993045730 rxcui: 1488569
FARXIGA	DAPAGLIFLOZIN	AstraZeneca Pharmaceuticals LP	72ad22ae-efe6-4cd6-a302-98aaee423d69	2026-06-03	Warnings, Adverse reactions	Exact identifier rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	AvKARE	52a778e7-6044-2049-e063-6294a90aa0b7	2026-05-27	Warnings, Adverse reactions	Exact identifier ndc (package): 73190-073-30 ndc (package): 73190-073-90 ndc (product): 73190-073 ndc11 (package): 73190007330 ndc11 (package): 73190007390 rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	A-S Medication Solutions	addc6ead-f9e3-4b40-aed1-bc008a5c9b0f	2026-05-18	Warnings, Adverse reactions	Exact identifier ndc (package): 50090-7972-0 ndc (product): 50090-7972 ndc11 (package): 50090797200 rxcui: 1488569
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Alembic Pharmaceuticals Limited	d44f7eed-dd51-40d1-8408-8fb331e1f1f6	2026-04-21	Warnings, Adverse reactions	Exact identifier ndc (package): 46708-393-30 ndc (package): 46708-393-91 ndc (product): 46708-393 ndc11 (package): 46708039390 ndc11 (package): 46708039330 ndc11 (package): 46708039391 rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	Apotex Corp.	bd9766c5-104f-4636-897d-b6c92eb94f18	2026-04-10	Warnings, Adverse reactions	Exact identifier ndc (package): 60505-4912-3 ndc (product): 60505-4912 ndc11 (package): 60505491203 rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	Zydus Lifesciences Limited	db668c5c-2d49-41c8-8ffd-c2b2652b621a	2026-04-06		Exact identifier ndc (package): 70771-1715-3 ndc (package): 70771-1715-9 ndc (product): 70771-1715 ndc11 (package): 70771171509 ndc11 (package): 70771171503 rxcui: 1488569
Dapagliflozin	DAPAGLIFLOZIN	Lupin Pharmaceuticals, Inc.	08baca21-e39e-4e61-961f-d89432fe8007	2026-04-02	Warnings, Adverse reactions	Exact identifier ndc (package): 70748-106-06 ndc (product): 70748-106 ndc11 (package): 70748010606 rxcui: 1488569
DAPAGLIFLOZIN	DAPAGLIFLOZIN	Biocon Pharma Inc.	828f1004-3647-9a13-8008-c4b3759ecfd0	2026-02-12	Warnings, Adverse reactions	Exact identifier ndc (package): 70377-024-11 ndc (package): 70377-024-12 ndc (product): 70377-024 ndc11 (package): 70377002411 ndc11 (package): 70377002412 rxcui: 1488569

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 25 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
979205ee-b0b8-4483-ae61-f283f750bb7f	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	101	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20240808
72ad22ae-efe6-4cd6-a302-98aaee423d69	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	45	These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA ® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014	20241024
40cc4f5d-bcf6-4016-9d1e-838bbc4bdddc	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	20	These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA ® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014	20240829
01f90c94-71cb-4a1f-81ff-8004b850529b	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	15	These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA ® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014	20231212
08baca21-e39e-4e61-961f-d89432fe8007	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	14	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260402
828f1004-3647-9a13-8008-c4b3759ecfd0	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260212
840e2146-2383-489b-bcc4-fecfe986685a	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	11	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260407
f615d81e-d1e8-4561-a4d9-286c615d3bd2	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	10	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20250811
b6b8a10c-64c3-4856-8961-d72d68784f5d	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	9	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260320
3aba33aa-f8c6-4b10-85c8-dfa14578d07c	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	9	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20241024
db668c5c-2d49-41c8-8ffd-c2b2652b621a	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	6	Dapagliflozin Tablets	20260406
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	5	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260408
0406a1c0-56b1-4ea1-95ae-00357ac1ba7e	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	5	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20251031
87521963-0d2a-4a2a-89c6-d50e8582419e	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	4	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20240628
20a83ea2-6ad8-4bbb-b516-73c0a9e37399	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260428
17586ec6-0104-4b08-ad87-12a837568d6c	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260406
52a778e7-6044-2049-e063-6294a90aa0b7	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	2	DAPAGLIFLOZIN tablets, for oral use These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. Initial U.S. Approval: 2014	20260527
f56593f7-588e-489d-9fad-b459e90dab18	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260511
bd9766c5-104f-4636-897d-b6c92eb94f18	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260410
107b4d25-4764-42b7-80e3-9aaff20865ed	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260408
91373924-66dc-4277-aaf2-8536e81a0e4d	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260407
addc6ead-f9e3-4b40-aed1-bc008a5c9b0f	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260518
6425d240-5dd9-4a2c-9348-f8a859702850	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260513
d44f7eed-dd51-40d1-8408-8fb331e1f1f6	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260407
8296f538-4c23-4d6c-be53-8005b83c24b7	dapagliflozin 10 MG Oral Tablet [PSN] · dapagliflozin 10 MG Oral Tablet [SCD] · dapagliflozin 10 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	20260331

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
8296f538-4c23-4d6c-be53-8005b83c24b7	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Sandoz Inc	20260730
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260717
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260716
91373924-66dc-4277-aaf2-8536e81a0e4d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Macleods Pharmaceuticals Limited	20260709
20a83ea2-6ad8-4bbb-b516-73c0a9e37399	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Florida Pharmaceutical Products, LLC \| Inventia Healthcare Limited. \| Inventia Healthcare Limited	20260702
6425d240-5dd9-4a2c-9348-f8a859702850	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	ANI Pharmaceuticals, Inc.	20260629
b6b8a10c-64c3-4856-8961-d72d68784f5d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Ascend Laboratories, LLC \| Alkem Laboratories Limited	20260625
840e2146-2383-489b-bcc4-fecfe986685a	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	20260623
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets USP, for oral use Initial U.S. Approval: 2014	Cipla USA Inc. \| Cipla Limited \| MSN Laboratories Private Limited \| CIPLA LIMITED GOA	20260622
17586ec6-0104-4b08-ad87-12a837568d6c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Zydus Pharmaceuticals USA Inc. \| Zydus Lifesciences Limited	20260622
107b4d25-4764-42b7-80e3-9aaff20865ed	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Novadoz Pharmaceuticals LLC \| MSN LABORATORIES PRIVATE LIMITED \| MSN Pharmaceuticals Inc.	20260617
b6b8a10c-64c3-4856-8961-d72d68784f5d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Ascend Laboratories, LLC \| Alkem Laboratories Limited	20260616
91373924-66dc-4277-aaf2-8536e81a0e4d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Macleods Pharmaceuticals Limited	20260608
3aba33aa-f8c6-4b10-85c8-dfa14578d07c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Prasco Laboratories \| AstraZeneca PLC	20260603
3aba33aa-f8c6-4b10-85c8-dfa14578d07c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Prasco Laboratories \| AstraZeneca PLC	20260603
52a778e7-6044-2049-e063-6294a90aa0b7	DAPAGLIFLOZIN tablets, for oral use These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. Initial U.S. Approval: 2014	AvKARE	20260527
52a778e7-6044-2049-e063-6294a90aa0b7	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	AvKARE	20260525
addc6ead-f9e3-4b40-aed1-bc008a5c9b0f	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	A-S Medication Solutions	20260518
6425d240-5dd9-4a2c-9348-f8a859702850	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	ANI Pharmaceuticals, Inc.	20260513
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260511
20a83ea2-6ad8-4bbb-b516-73c0a9e37399	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Florida Pharmaceutical Products, LLC \| Inventia Healthcare Limited. \| Inventia Healthcare Limited	20260428
840e2146-2383-489b-bcc4-fecfe986685a	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	20260422
d44f7eed-dd51-40d1-8408-8fb331e1f1f6	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Limited	20260421
bd9766c5-104f-4636-897d-b6c92eb94f18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Apotex Corp. \| Aizant Drug Research Solutions Pvt Ltd	20260410
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Cipla USA Inc. \| Cipla Limited \| MSN Laboratories Private Limited \| CIPLA LIMITED GOA	20260408
107b4d25-4764-42b7-80e3-9aaff20865ed	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Novadoz Pharmaceuticals LLC \| MSN LABORATORIES PRIVATE LIMITED	20260408
107b4d25-4764-42b7-80e3-9aaff20865ed	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Novadoz Pharmaceuticals LLC \| MSN LABORATORIES PRIVATE LIMITED	20260408
840e2146-2383-489b-bcc4-fecfe986685a	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Inc. \| Alembic Pharmaceuticals Limited	20260407
91373924-66dc-4277-aaf2-8536e81a0e4d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Macleods Pharmaceuticals Limited	20260407
d44f7eed-dd51-40d1-8408-8fb331e1f1f6	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Alembic Pharmaceuticals Limited	20260407
f56593f7-588e-489d-9fad-b459e90dab18	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Aurobindo Pharma Limited \| APL HEALTHCARE LIMITED	20260407
db668c5c-2d49-41c8-8ffd-c2b2652b621a	Dapagliflozin Tablets	Zydus Lifesciences Limited	20260406
17586ec6-0104-4b08-ad87-12a837568d6c	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Zydus Pharmaceuticals USA Inc. \| Zydus Lifesciences Limited	20260406
a2f86c0a-ce78-4d06-b5d8-ed457c8e3614	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Cipla USA Inc. \| Cipla Limited \| MSN Laboratories Private Limited \| CIPLA LIMITED GOA	20260404
08baca21-e39e-4e61-961f-d89432fe8007	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	20260402
8296f538-4c23-4d6c-be53-8005b83c24b7	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Sandoz Inc	20260331
b6b8a10c-64c3-4856-8961-d72d68784f5d	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Ascend Laboratories, LLC \| Alkem Laboratories Limited	20260320
828f1004-3647-9a13-8008-c4b3759ecfd0	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Biocon Pharma Inc. \| Biocon Pharma Limited \| Biocon Limited \| Syngene International Limited	20260212
0406a1c0-56b1-4ea1-95ae-00357ac1ba7e	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Teva Pharmaceuticals, Inc.	20251031
0406a1c0-56b1-4ea1-95ae-00357ac1ba7e	These highlights do not include all the information needed to use DAPAGLIFLOZIN TABLETS safely and effectively. See full prescribing information for DAPAGLIFLOZIN TABLETS. DAPAGLIFLOZIN tablets, for oral use Initial U.S. Approval: 2014	Teva Pharmaceuticals, Inc.	20251031

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	A10BK	Sodium-glucose co-transporter 2 (SGLT2) inhibitors	ATC1-4		dapagliflozin
FDASPL	N0000187059	Sodium-Glucose Cotransporter 2 Inhibitor	EPC	has_epc	dapagliflozin
FDASPL	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	MOA	has_moa	dapagliflozin
MEDRT	D001559	Benzhydryl Compounds	CHEM	has_ingredient	dapagliflozin
MEDRT	D005960	Glucosides	CHEM	has_ingredient	dapagliflozin
MEDRT	D003924	Diabetes Mellitus, Type 2	DISEASE	may_treat	dapagliflozin
MEDRT	D006333	Heart Failure	DISEASE	may_treat	dapagliflozin
MEDRT	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	MOA	has_moa	dapagliflozin
MEDRT	N0000175650	Decreased Sympathetic Activity	PE	has_pe	dapagliflozin
MEDRT	N0000009556	Increased Renal Organic Ion Excretion	PE	has_pe	dapagliflozin
MEDRT	N0000009830	Renal Ion Transport Alteration	PE	has_pe	dapagliflozin

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Farxiga	rxnav_allrelated
DF	DF	Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	dapagliflozin	rxnav_allrelated
SBD	SBD	dapagliflozin 10 MG Oral Tablet [Farxiga]	rxnav_allrelated
SBDC	SBDC	dapagliflozin 10 MG [Farxiga]	rxnav_allrelated
SBDF	SBDF	dapagliflozin Oral Tablet [Farxiga]	rxnav_allrelated
SBDG	SBDG	Farxiga Oral Product	rxnav_allrelated
SBDG	SBDG	Farxiga Pill	rxnav_allrelated
SCD	SCD	dapagliflozin 10 MG Oral Tablet	rxnav_allrelated
SCDC	SCDC	dapagliflozin 10 MG	rxnav_allrelated
SCDF	SCDF	dapagliflozin Oral Tablet	rxnav_allrelated
SCDG	SCDG	dapagliflozin Oral Product	rxnav_allrelated
SCDG	SCDG	dapagliflozin Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	10 MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA211156
CODES	ANDA	ANDA211312
CODES	ANDA	ANDA211468
CODES	ANDA	ANDA211470
CODES	ANDA	ANDA211478
CODES	ANDA	ANDA211482
CODES	ANDA	ANDA211506
CODES	ANDA	ANDA211523
CODES	ANDA	ANDA211531
CODES	ANDA	ANDA211535
CODES	ANDA	ANDA211541
CODES	ANDA	ANDA211545
CODES	ANDA	ANDA211560
CODES	ANDA	ANDA211582
CODES	SNOMEDCT	1145541007
CODES	VUID	4033037
NAMES	Prescribable Synonym	dapagliflozin 10 MG Oral Tablet
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	US Edition of SNOMED_CT
SOURCES	Source	Veterans Health Administration National Drug File